Compile Data Set for Download or QSAR
Report error Found 9 Enz. Inhib. hit(s) with all data for entry = 8986
TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434771BDBM434771(US10562910, Example 2)
Affinity DataEC50:  5.10nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434774BDBM434774(US10562910, Example 14)
Affinity DataEC50:  15.5nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434772BDBM434772(US10562910, Example 11)
Affinity DataEC50:  17nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434773BDBM434773(US10562910, Example 13)
Affinity DataEC50:  19.5nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434776BDBM434776(US10562910, Example 5)
Affinity DataEC50:  25.7nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434775BDBM434775(US10562910, Example 6)
Affinity DataEC50:  31nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434770BDBM434770(US10562910, Example 1)
Affinity DataEC50:  49.3nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434777BDBM434777(US10562910, Example 4)
Affinity DataEC50:  60.4nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetBile acid receptor(Human)
North & South Brother Pharmacy Investment

US Patent
LigandChemical structure of BindingDB Monomer ID 434778BDBM434778(US10562910, Example 3)
Affinity DataEC50:  76.1nMAssay Description:Purchasing invitrogen PV4833 kits. The procedure refers to LanthaScreen TR-FRET Farnesoid X Receptor Coactivator AssayFirst, the required amount of t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent